ReviewFrontiers in cellular and infection microbiology2025
Combating antimicrobial resistance in Africa: a strategic roadmap for surveillance, stewardship, and research.
Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Africa stands at a pivotal moment in public health: the continent faces a high and growing burden of infectious diseases driven in part by antimicrobial resistance (AMR) yet remains underrepresented in global clinical research and surveillance initiatives. Despite advances in technology, infrastructure and human capital in some regions, persistent gaps in laboratory capacity, epidemiologic surveillance, data systems, governance, funding and clinical research impede timely detection, containment and evidence-based management of drug-resistant infections. This review synthesizes the current landscape of AMR surveillance and clinical research capacity across African countries, highlighting the major structural and often over-looked barriers and also exemplary local initiatives that demonstrate scalable progress. We argue that linking strengthened AMR surveillance with concerted investment in clinical research, laboratory networks, antimicrobial stewardship, data governance and policy reforms will enable a shift from reactive responses to proactive, system-wide AMR prevention and containment strategies. Drawing on published literature, policy documents and regional case studies, this review proposed a practical, phased roadmap for integrated surveillance-led healthcare reform tailored to African contexts and realities, with concrete recommendations. It also defined actionable priorities and framework to accelerate AMR detection, research, and containment across Africa, ultimately reducing the burden of drug-resistant infections and strengthening health system resilience in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.